Partner Content Partner Content Ensuring a more informed and effective oncology drug develop... The rush to discover the next big frontier in cancer medicine is more evident than it ever has been since the introduction of targeted therapies.
Partner Content Partner Content VIDEO: Streamlining the process of patient enrollment Ever more-specific cancer medicines carry the advantage of more personalised treatments for those with the disease.
Partner Content Partner Content On Demand: The Top 5 Challenges in Immuno-Oncology Trials In the battle against cancer, immunotherapy is proving to be one of the most promising avenues of research.
News FDA starts review of Regeneron's drug for rare disease FOP Can Regeneron's drug for ultra-rare bone disease FOP pick up the baton from Ipsen's Sohonos, whose growth has stalled?
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
